The abstract is read at the publisher; the summary is JClub's.
Opt-out referral to embedded smoking cessation programs in real-world lung cancer screening shows consistently high uptake, while program-level implementation factors are rarely reported across 55 studies.
- Why it matters: Even though cessation support is recommended for lung cancer screening, how these interventions are implemented outside trials is poorly understood, limiting scalable integration.
- What they did: A RE-AIM-guided scoping review of 55 nontrial studies (2013 onward) searched six databases in February 2025 plus grey literature, then mapped intervention and implementation details across Reach, Effectiveness, Adoption, Implementation, and Maintenance.
- The result: Most interventions were behavioral (96%) and/or pharmacological (58%), with relatively higher cessation outcomes for more intensive group or multicomponent approaches, but Adoption (7%), Implementation (5%), and Maintenance (4%) reporting was uncommon.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.